• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB 4.88% 3.9¢

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - News & Media

NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged... NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer's disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury.More

(20min delay)
Last
3.9¢
Change
-0.002(4.88%)
Mkt cap ! $5.639M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $2.493K 63.93K

Buyers (Bids)

No. Vol. Price($)
1 21089 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 53499 2
View Market Depth
Last trade - 15.14pm 18/10/2024 (20 minute delay) ?
Last
3.9¢
  Change
-0.002 ( 2.50 %)
Open High Low Volume
3.8¢ 4.0¢ 3.8¢ 85250
Last updated 13.26pm 18/10/2024 ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.